# Rescuing SERCA2 pump deficiency: A novel approach to improve bone mechano-responsiveness in type 2 diabetes

## TL;DR

This study shows that restoring a specific protein in bone cells can improve bone strength in type 2 diabetes by enhancing how bones respond to mechanical stress.

## Contribution

The study identifies SERCA2 pump deficiency in osteocytes as a novel target for improving bone mechano-responsiveness in type 2 diabetes.

## Key findings

- T2D mice show reduced bone mechano-responsiveness due to impaired calcium dynamics in osteocytes.
- SERCA2 deficiency in osteocytes is mediated by PPARα in T2D.
- SERCA2 overexpression in osteocytes reduces T2D-induced bone deterioration.

## Abstract

A recent study published in Nature Communications demonstrated that restoring SERCA2 pump deficiency can enhance bone mechano-responsiveness in type 2 diabetes (T2D) by modulating osteocyte calcium dynamics. The findings revealed that in T2D mice, the ability of the bone to respond to mechanical stress is compromised, primarily due to attenuated calcium oscillatory dynamics within osteocytes rather than in osteoblasts or osteoclasts. The underlying mechanism of this reduction in bone mechano-responsiveness in T2D was identified as a specific decrease in osteocytic SERCA2 expression mediated by PPARα. Additionally, mice overexpressing SERCA2 in osteocytes exhibited reduced deterioration of bone mechano-responsiveness induced by T2D. Collectively, this study provides mechanistic insights into T2D-induced deterioration in bone mechano-responsiveness and identifies a promising therapeutic approach to counteract T2D-associated fragility fractures.